Advanced Sterilization Products (ASP) has won four awards in the Medical Devices Network Excellence Awards in the Innovation, Product Launches, Safety, and Environmental categories for their pioneering work in sterilization technology.
The Medical Device Network Excellence Awards celebrate the greatest achievements and innovations in the medical devices industry. Powered by GlobalData’s business intelligence, the Awards recognize the people and companies that are driving change in the industry.
Go deeper with GlobalData
Advanced Sterilization Products won the Innovation award for pioneering the first FDA-cleared hydrogen peroxide gas plasma sterilization method for duodenoscopes, enhancing patient safety. The Product Launch award was secured through strategic collaboration with PENTAX® Medical, demonstrating successful industry partnerships. ASP’s commitment to environmental sustainability, evidenced by significant reductions in energy and water usage, earned them the Environmental award. Lastly, the Safety award recognized their advanced sterilization solutions that protect both patients and healthcare workers by minimizing contamination risks and exposure to hazardous materials.
Setting new standards in sterilization technology through innovation
ASP’s ULTRA GI™ Cycle represents a groundbreaking advancement in sterilization technology, particularly for the reprocessing of duodenoscopes. By introducing the first FDA-cleared hydrogen peroxide gas plasma sterilization method for these complex medical devices, ASP has addressed a critical gap in patient safety.
This innovation transitions the process from high-level disinfection to terminal sterilization, significantly enhancing the margin of safety. The ULTRA GI™ Cycle, with its 68-minute cycle time, is specifically designed for reprocessing H2O2-compatible duodenoscopes, boosting efficiency in healthcare settings and making it an essential solution for sterile processing departments.
Additionally, the rigorous FDA clearance process that the ULTRA GI™ Cycle underwent validates its safety and effectiveness, providing healthcare facilities with confidence in its use. This innovation sets a new industry standard for sterilization efficacy and reliability in reprocessing.
Product launch success: Strategic collaborations
The launch of the ULTRA GI™ Cycle was marked by strategic collaboration with PENTAX® Medical, showcasing ASP’s ability to drive industry innovation through partnerships. This collaboration highlights the synergy between leading organizations in the medical device industry, combining expertise to deliver cutting-edge solutions.
The product launch was bolstered by strong endorsements from industry leaders and backed by robust clinical data, ensuring credibility and trust in the market. By addressing a significant industry need, ASP has received positive responses from the clinical community and medical device manufacturers. The enhancement of the ULTRA GI™ Cycle with the globally trusted STERRAD™ 100NX Sterilizer, featuring the latest technological advancements, further solidifies ASP’s position as a leader in sterilization solutions. The launch was also marked by an FDA clearance that reflects rigorous evaluation and endorsement of its effectiveness and safety, ensuring market credibility and trust. This strategic approach to product launches demonstrates ASP’s commitment to meeting the evolving needs of healthcare professionals.
Pioneering eco-friendly sterilization solutions
ASP’s dedication to environmental sustainability is evident in the design of the STERRAD™ 100NX Sterilizer with ALLClear™ Technology. These systems significantly lower energy consumption by approximately 70% compared to traditional steam sterilizers, contributing to a reduced carbon footprint. Additionally, they conserve water, saving substantial amounts annually, which is particularly beneficial in regions facing water scarcity.
The environmentally friendly gas plasma technology breaks down hydrogen peroxide into water and oxygen, reducing harmful emissions and fostering a healthier work environment. By preserving the integrity of medical instruments, STERRAD™ Systems not only extend the life of devices compared to traditional steam sterilizers, but also reduces reliance on single-use scopes, minimizing medical waste and promoting sustainable practices. This approach not only benefits the environment, but also offers cost savings for healthcare facilities by reducing the need for repairs and replacements. ASP’s commitment to sustainability is reflected in the overall design of their sterilization systems, which prioritize both environmental responsibility and operational efficiency.
Enhancing safety standards in healthcare sterilization
Safety is at the core of ASP’s innovations, and the ULTRA GI™ Cycle exemplifies their commitment to advancing validations for complex medical devices in terminal sterilization. This promotes higher standards in endoscope reprocessing, mitigating risks associated with patient outcomes. The touch-free cassette disposal system enhances the safety of sterile processing staff by reducing direct contact with hazardous materials. Additionally, the incorporation of the ALLClear™ Technology, which integrates pre-cycle load conditioning and moisture detection, reduces the risk of incomplete sterilization, ensuring the highest standards of safety for both patients and healthcare workers.
ASP’s focus on safety is evident in the design of their Hydrogen Peroxide Gas Plasma (HPGP) systems, which utilizes gas plasma technology to break down hydrogen peroxide into benign byproducts, preventing a burst of hydrogen peroxide vapor when the chamber is open. This process ensures no release of carcinogenic fumes and safeguards operator safety by minimizing residual exposure risks. This comprehensive approach to safety not only protects patients, but also provides healthcare workers with a reliable and secure sterilization process, reinforcing ASP’s commitment to advancing healthcare safety standards.
“We are proud to be recognized by the Medical Device Network Excellence Awards 2024 receiving four prestigious awards across several key categories for the ULTRA GI™ Cycle and STERRAD™ 100NX Sterilizer with ALLClear™ Technology. This recognition is a testament to the dedication and innovation of the ASP team in advancing sterilization technology and embodying our mission to protect patients in their most critical moments. The ULTRA GI Cycle is the first FDA-cleared sterilization solution for duodenoscopes using hydrogen peroxide gas plasma, addressing a critical gap in patient safety. This gas plasma technology not only sterilizes effectively but also breaks hydrogen peroxide down into benign byproducts, significantly minimizing residual exposure risks and enhancing safety for caregivers and the environment.” – Chad Rohrer, President, Advanced Sterilization Products
Company Profile
Advanced Sterilization Products has a long track record of designing and delivering innovative infection prevention solutions that dramatically raise the level of health care and safety for those who matter most. Our pioneering technology, global distribution and established leadership position enable us to simplify the process of buying and operating infection prevention products and services every day for thousands of medical facilities around the world. This enables our customers to focus on what they do best – preventing infection and saving lives. For more information, please visit www.asp.com.
Links
Website: www.asp.com
